RCE 1.04% 48.5¢ recce pharmaceuticals ltd

Ann: Positive Sinusitis Patient Update - Special Access Scheme, page-9

  1. 16 Posts.
    lightbulb Created with Sketch. 3
    Recce may have saved a life....... that is huge

    Within 90 minutes, Patient X recorded their sinuses began to feel clearer, less inflamed
    and reported less discharge. As Patient X continued their dosing program, it was recorded
    the stinging sensation subsided over time. Over a three-day period of applying R327 topically
    via spray to the infected areas in the sinus', Patient X reported a substantial reduction in
    infected discharge, termination of sweating and a return to normal sleeping patterns with no
    side effects. Post-dosing program, blood samples were taken and tested. These samples
    showed no detectable signs of P. aeruginosa infection and no abnormalities.
    Not long after the dosing program, the patient reported feeling a return of the initial infection.
    Following a sinus biopsy, an opportunistic ‘common bacterium’ had taken residence where
    the P. aeruginosa was previously. Having advanced from a life-threating infection status, it
    was agreed that the new, unrelated bacterial infection was early in its growth. A course of
    Septrim Forte cleared the opportunistic bacteria and the initial drug resistant P. aeruginosa
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
48.5¢
Change
0.005(1.04%)
Mkt cap ! $112.3M
Open High Low Value Volume
48.0¢ 48.5¢ 47.0¢ $57.12K 120.0K

Buyers (Bids)

No. Vol. Price($)
1 6317 47.5¢
 

Sellers (Offers)

Price($) Vol. No.
49.0¢ 1200 1
View Market Depth
Last trade - 15.58pm 15/08/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.